Press-release for stocks related to market

Prices are updated after-hours

tags : Market source : Www.biospace.com

save search

BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule - April 11, 2024
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
BCLI | $0.5275 -3.86% -4.02% 620K

Health Technology

| -7.16% | O: -0.17% H: 13.56% C: -2.19%
nasdaq cell therapeutics market

Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
Published: 2024-04-10 (Crawled : 13:00) - biospace.com/
GKOS M | $97.7 0.89% 200K

Health Technology

| -4.41% | O: -2.14% H: 1.92% C: 0.57%
first financial results market

RenovoRx Announces $11.1 Million at Market Private Placement
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
RNXT | $1.15 20K

| -1.71% | O: -1.71% H: 34.78% C: 1.74%
million market

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
RDHL | $0.35 -13.41% -15.49% 980K

Health Technology

| -24.87% | O: -5.2% H: 4.9% C: 3.92%
million direct offering biopharma market

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: Glo...
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | $92.966 -2.18% 630

Health Technology

| -7.0% | O: -0.26% H: 0.0% C: 0.0%
SNY | $46.05 -0.41% 940K

Health Technology

| -4.74% | O: 1.06% H: 0.0% C: 0.0%
copd potential market

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData
Published: 2024-03-27 (Crawled : 12:30) - biospace.com/
SNYNF | $92.966 -2.18% 630

Health Technology

| -7.0% | O: -0.26% H: 0.0% C: 0.0%
SNY | $46.05 -0.41% 940K

Health Technology

| -4.74% | O: 1.06% H: 0.0% C: 0.0%
copd potential market

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
Published: 2024-03-22 (Crawled : 21:00) - biospace.com/
AZZ | $76.385 -0.71% 0.0% 97K

Producer Manufacturing

| -6.04% | O: -1.74% H: 0.37% C: -3.24%
india agreement market

Avenacy Announces Launch of Furosemide for Injection in the U.S. Market
Published: 2024-03-20 (Crawled : 12:30) - biospace.com/
SNYNF | $92.966 -2.18% 630

Health Technology

| -2.01% | O: -0.01% H: 0.0% C: 0.0%
SNY | $46.05 -0.41% 940K

Health Technology

| -0.92% | O: 0.03% H: 0.0% C: 0.0%
injection market

Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®
Published: 2024-02-29 (Crawled : 17:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M

Health Technology

| -8.38% | O: 0.56% H: 0.12% C: -0.38%
stelara biosimilar market

GSK, Sanofi Exit Nigerian Market Amid Lingering Foreign Exchange Crisis
Published: 2024-02-28 (Crawled : 06:00) - biospace.com/
SNY | $46.05 -0.41% 940K

Health Technology

| -3.06% | O: -0.63% H: 0.0% C: 0.0%
sanofi market

How Upcoming KRAS Inhibitors are Expected to Shape the Future Oncology Market Landscape?
Published: 2024-02-26 (Crawled : 17:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M

Health Technology

| -8.27% | O: 0.52% H: 0.0% C: 0.0%
RVMD S | $36.29 2.11% 2.07% 1.2M

Health Technology

| 19.5% | O: 0.4% H: 2.75% C: 1.74%
IOVA | $11.91 0.17% 0.17% 5.4M

Health Technology

| -24.6% | O: 0.19% H: 9.37% C: 5.06%
expected market

Opinion: 2024 Will Be a Buyers’ Market in Biopharma. It Already Is.
Published: 2024-02-21 (Crawled : 06:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M

Health Technology

| -5.87% | O: 0.8% H: 0.0% C: 0.0%
market

Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023
Published: 2024-02-20 (Crawled : 17:00) - biospace.com/
MS | $89.14 2.47% 0.0% 18M

Finance

| 1.5% | O: -0.65% H: 0.64% C: -0.69%
JNJ | $144.45 -2.13% 0.03% 13M

Health Technology

| -5.76% | O: 0.12% H: 0.0% C: 0.0%
LLY | $746.74 -0.54% 1.01% 2.5M

Health Technology

| -4.0% | O: 1.02% H: 0.43% C: -4.35%
biopharma market

Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules
Published: 2024-02-20 (Crawled : 13:30) - biospace.com/
BFRI | $1.81 10.37% 9.39% 48K

| 118.81% | O: 69.45% H: 48.03% C: -9.45%
nasdaq million market

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024
Published: 2024-02-14 (Crawled : 12:00) - biospace.com/
UTHR | $231.425 -1.56% 220K

Health Technology

| 9.98% | O: -0.29% H: 0.72% C: 0.61%
report year corporation therapeutics financial results market

Poolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRS
Published: 2024-02-12 (Crawled : 10:00) - biospace.com/
ARVL | $0.49 0.37% 2.5M

Manufacturing

| Email alert Add to watchlist
AMYT | $14.7 0.0% 2.4M

Health Technology

| Email alert Add to watchlist
pharma market

Alto, Fractyl Go Public in Back-to-Back Offerings as IPO Market Heats Up
Published: 2024-02-02 (Crawled : 15:00) - biospace.com/
MS | $89.14 2.47% 0.0% 18M

Finance

| 1.13% | O: -0.4% H: 1.39% C: 0.93%
market